Hims & Hers launched its weight loss program in December and recently added compounded GLP-1 medications to its offerings
CrossRef Postoperative adjuvant TACE combined with lenvatinib and immune checkpoint inhibitors for hepatocellular carcinoma with high recurrence risks: a multicenter retrospective study Ziyue Huang, Taifeng Zhu, Xiaokun Chen, Mingjian Piao, Yang Tan, Chengjie Li, Kai Liu, Shanshan Wang, Lei Zhang, Shunda Du, Chengpei Zhu, Kang Zhou, Xiaobo Yang, Daobing Zeng, Haitao Zhao BMC Cancer .2026;[Epub] CrossRef SLC25A39 binds and modulates PRDX1 to suppress ROS-induced necroptosis in hepatocellular carcinoma Wenxuan Liu, Tianrui Kuang, Keshuai Dong, Man Li, Wenhong Deng, Jia Yu International Immunopharmacology .2026
Industry Definition & Background Retatrutide (also known as LY3437943) is a synthetic peptide triple agonist developed for the treatment of obesity, type 2 diabetes, and metabolic syndrome
Its sold under the brand names Adipex-P, Lomaira, and Suprenza
Tiered Pricing Options: Provide different service levels, such as basic (GLP-1 only) and premium (GLP-1 + nutritional coaching, lab tests, or personalized plans)
There is currently no confirmed causal link between retatrutide and depression based on published Phase 2 trial data
